Dear Sir/Ma''am, Please find enclosed report on action under the Special Window for re-lodgement of transfer requests for the month of September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has submitted a report to BSE on the SEBI Special Window for re-lodgement of physical share transfer requests for the month of September 2025, filed under SEBI Circular dated July 2, 2025. The company's Registrar, Alankit Assignments Limited, confirmed that the number of requests received, processed, approved, and rejected during September 2025 was NIL in every category. The report was signed by the Registrar's General Manager and the company's Managing Director on October 28, 2025. This is a routine monthly compliance submission with zero shareholder activity to report for the period.
No material impact on shareholders or the stock — the filing is purely procedural and indicates no shareholders sought to re-lodge physical share transfer requests during September 2025.